Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
High-Risk Diagnosis Codes Z72.51 High risk heterosexual behavior Z72.52 High risk homosexual behavior Z72.53 High risk bisexual behavior Z77.29 Exposure to hazardous substances Z77.9 Other exposure hazardous to health Z91.89 Other specified personal risk factors Z92.89 History of other medical treatment Low-Risk Diagnosis Codes Z01.411 Routine gynecological exam with abnormal findings Z01.419 Routine gynecological exam without abnormal findings Z12.4 Cervical cancer screening Z12.72 Vaginal cancer screening Z12.79 Screening for other genitourinary malignancies Z12.89 Screening for malignancy at other sites Pre-existing Diagnosed Conditions R87.622 (Low-grade squamous intraepithelial lesion) R87.610 (Atypical squamous cells of undetermined significance) Providers should verify coding updates annually, as diagnosis code qualifiers may shift due to clinical guideline revisions
Research goals: Longevity & Anti-Aging, Metabolic & Weight Description 5-Amino-1MQ (5-amino-1-methylquinolinium iodide) is a small-molecule, membrane-permeable inhibitor of nicotinamide N-methyltransferase (NNMT), the enzyme that converts nicotinamide and S-adenosyl-l-methionine (SAM) into 1-methylnicotinamide and S-adenosyl-l-homocysteine
A preclinical safety evaluation published in ScienceDirect confirmed that BPC-157 caused mild local irritation but demonstrated good overall tolerance across mice, rats, rabbits, and dogs
Mistriotis, P., Wisniewski, E
US$ 21.68
US$ 26.09
US$ 24.18
US$ 29.17
US$ 27.09
US$ 25.95